Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Goodwill (2016 - 2026)

Nutex Health (NUTX) has disclosed Goodwill for 14 consecutive years, with $13.9 million as the latest value for Q1 2026.

  • For Q1 2026, Goodwill changed 0.0% year-over-year to $13.9 million; the TTM value through Mar 2026 reached $13.9 million, changed 0.0%, while the annual FY2025 figure was $13.9 million, 0.0% changed from the prior year.
  • Goodwill hit $13.9 million in Q1 2026 for Nutex Health, roughly flat from $13.9 million in the prior quarter.
  • Across five years, Goodwill topped out at $416.4 million in Q3 2024 and bottomed at $13.9 million in Q2 2024.
  • Average Goodwill over 5 years is $63.6 million, with a median of $17.0 million recorded in 2022.
  • Year-over-year, Goodwill soared 2226.2% in 2024 and then crashed 96.66% in 2025.
  • Nutex Health's Goodwill stood at $17.0 million in 2022, then grew by 0.33% to $17.1 million in 2023, then decreased by 18.44% to $13.9 million in 2024, then changed by 0.0% to $13.9 million in 2025, then changed by 0.0% to $13.9 million in 2026.
  • According to Business Quant data, Goodwill over the past three periods came in at $13.9 million, $13.9 million, and $13.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.